Entering text into the input field will update the search result below

The integrity of research into Medtronic's (NYSE:MDT) bone-growth protein Infuse, which is used...

Oct. 25, 2012 3:48 AM ETMedtronic plc (MDT) StockMDTBy: Yigal Grayeff, SA News Editor
The integrity of research into Medtronic's (NYSE:MDT) bone-growth protein Infuse, which is used in spine surgery, has been called into question by a Senate Finance Committee report that says the company was "heavily involved in drafting, editing and shaping the content of medical journal articles" about the product. Medtronics also paid $210M for unrelated work to the doctors who wrote the articles.

Recommended For You

More Trending News

About MDT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDT--
Medtronic plc